These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9041753)

  • 41. Human papillomavirus: science and technologies for the elimination of cervical cancer.
    Bosch FX
    Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
    Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical cancer screening in France.
    Schaffer P; Sancho-Garnier H; Fender M; Dellenbach P; Carbillet JP; Monnet E; Gauthier GP; Garnier A
    Eur J Cancer; 2000 Nov; 36(17):2215-20. PubMed ID: 11072207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integration of comprehensive women's health programmes into health systems: cervical cancer prevention, care and control in Rwanda.
    Binagwaho A; Ngabo F; Wagner CM; Mugeni C; Gatera M; Nutt CT; Nsanzimana S
    Bull World Health Organ; 2013 Sep; 91(9):697-703. PubMed ID: 24101786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proposal to institutionalize criteria and quality standards for cervical cancer screening within a health care system.
    Salmerón-Castro J; Kazcano Ponce EC; Pérez Cuevas R; del Río Gómez I; Torres Torija I; Hernández Avila M
    Cad Saude Publica; 1998; 14 Suppl 3():67-75. PubMed ID: 9819465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London 17 January 2002. Cervical cancer in developing countries.
    Sankaranarayanan R
    Trans R Soc Trop Med Hyg; 2002; 96(6):580-5. PubMed ID: 12625127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of screening programmes for gynaecological cancer.
    Hakama M; Chamberlain J; Day NE; Miller AB; Prorok PC
    Br J Cancer; 1985 Oct; 52(4):669-73. PubMed ID: 4063143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishing Baseline Cervical Cancer Screening Coverage - India, 2015-2016.
    Van Dyne EA; Hallowell BD; Saraiya M; Senkomago V; Patel SA; Agrawal S; Ghosh A; Saraf D; Mehrotra R; Dhillon PK
    MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(1):14-19. PubMed ID: 30629571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a community cancer education program: the Forsyth County, NC cervical cancer prevention project.
    Michielutte R; Dignan MB; Wells HB; Young LD; Jackson DS; Sharp PC
    Public Health Rep; 1989; 104(6):542-51. PubMed ID: 2511586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NordScreen - an interactive tool for presenting cervical cancer screening indicators in the Nordic countries.
    Partanen VM; Anttila A; Heinävaara S; Pankakoski M; Sarkeala T; Bzhalava Z; Elfström KM; Tropé A; Skare GB; Thorsteinsdottir S; Ágústsson ÁI; Veerus P; Koreinik L; Dillner J; Lönnberg S
    Acta Oncol; 2019 Sep; 58(9):1199-1204. PubMed ID: 31106635
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of cervical cancer.
    Farnsworth A; Mitchell HS
    Med J Aust; 2003 Jun; 178(12):653-4. PubMed ID: 12797859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Past, present and future of the cervical cancer screening in Latvia.
    Viberga I; Engele L; Baili P;
    Tumori; 2010; 96(4):529-37. PubMed ID: 20968131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and mortality of cervical cancer in Latin America.
    Arrossi S; Sankaranarayanan R; Parkin DM
    Salud Publica Mex; 2003; 45 Suppl 3():S306-14. PubMed ID: 14746023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of cervical cancer and cervical screening: implications for nursing practice.
    Ibbotson T; Wyke S
    J Adv Nurs; 1995 Oct; 22(4):745-52. PubMed ID: 8708195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is it cost effective to introduce screening programmes for colorectal cancer? Illustrating the principles of optimal resource allocation.
    Gyrd-Hansen D
    Health Policy; 1997 Sep; 41(3):189-99. PubMed ID: 10170088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors affecting utilization of cervical cancer prevention services in low-resource settings.
    Bingham A; Bishop A; Coffey P; Winkler J; Bradley J; Dzuba I; Agurto I
    Salud Publica Mex; 2003; 45 Suppl 3():S408-16. PubMed ID: 14746034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer incidence and mortality: the priority of screening frequency and population coverage.
    Colditz GA; Hoaglin DC; Berkey CS
    Milbank Q; 1997; 75(2):147-73. PubMed ID: 9184680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnosis of capacity to perform essential public health functions in the Central American countries, the Dominican Republic, and the Mexican states of Chiapas and Quintana Roo].
    González Block MÁ; González Robledo LM; Cuadra Hernández SM
    Rev Panam Salud Publica; 2013 Apr; 33(4):271-9. PubMed ID: 23698176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using simulation-optimization to construct screening strategies for cervical cancer.
    McLay LA; Foufoulides C; Merrick JR
    Health Care Manag Sci; 2010 Dec; 13(4):294-318. PubMed ID: 20963551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervical cancer in the Republic of Panama.
    Reeves WC; Brenes MM; de Britton RC; Valdes PF; Joplin CF
    Am J Epidemiol; 1984 May; 119(5):714-24. PubMed ID: 6720669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.